logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12162870 B1

PDFFull Text
Date of Patent:
Dec. 10, 2024

Filed:

Jun. 08, 2022

Anticancer compounds

Applicants:

The Regents of the University of California, Oakland, CA (US);

Poseidon Innovation, Llc, New York, NY (US);

Inventors:

Andrew K. Shiau, San Diego, CA (US);

Mehmet Kahraman, La Jolla, CA (US);

Michael J. Bishop, San Diego, CA (US);

Assignees:

The Regents of the University of California, Oakland, CA (US);

Poseidon Innovation, LLC, New York, NY (US);

Attorneys:

Foley Hoag LLP

Dana M. Gordon

Laura A. Wzorek

Primary Examiner:

Rebecca L Anderson

Int. Cl.
CPC ...
C07D 413/10 (2006.01); A61P 35/00 (2006.01); C07C 233/25 (2006.01); C07C 233/43 (2006.01); C07D 209/14 (2006.01); C07D 211/58 (2006.01); C07D 213/40 (2006.01); C07D 231/12 (2006.01); C07D 231/38 (2006.01); C07D 233/64 (2006.01); C07D 267/14 (2006.01); C07D 295/135 (2006.01); C07D 401/04 (2006.01); C07D 401/10 (2006.01); C07D 401/14 (2006.01); C07D 413/04 (2006.01); C07D 413/12 (2006.01); C07D 487/10 (2006.01);
U.S. Cl.
CPC ...
C07D 413/10 (2013.01); A61P 35/00 (2018.01); C07C 233/25 (2013.01); C07C 233/43 (2013.01); C07D 209/14 (2013.01); C07D 211/58 (2013.01); C07D 213/40 (2013.01); C07D 231/12 (2013.01); C07D 231/38 (2013.01); C07D 233/64 (2013.01); C07D 267/14 (2013.01); C07D 295/135 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 401/14 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 487/10 (2013.01);
Abstract

Disclosed are compounds of formula (I): and pharmaceutically acceptable salts thereof. The compounds of the invention are BDII-selective inhibitors of BET proteins, and have therapeutic potential for treating cancer, acute kidney disease, and viral infections, among other diseases.

Find Patent Forward Citations

Shiau, Andrew. (2024). Anticancer compounds (U.S. Patent No. 12162870). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12162870

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…